HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
F Griesinger Selected Research
F Griesinger Research Topics
Disease
10
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 03/2012
5
Neoplasms (Cancer)
01/2022 - 09/2004
3
Lung Neoplasms (Lung Cancer)
08/2011 - 03/2010
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2004 - 10/2000
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2002 - 05/2001
2
Disease Progression
11/2022 - 01/2018
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2003 - 02/2002
1
Lymphopenia (Lymphocytopenia)
11/2022
1
Hypertension (High Blood Pressure)
11/2022
1
Neutropenia
11/2022
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1
Neoplasm Metastasis (Metastasis)
01/2022
1
Breast Neoplasms (Breast Cancer)
06/2019
1
Central Nervous System Diseases (CNS Diseases)
01/2018
1
Leukemia
05/2006
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2005
1
Pathologic Complete Response
11/2004
1
Graft vs Host Disease (Graft-Versus-Host Disease)
04/2003
1
Blast Crisis (Blast Phase)
04/2003
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2002
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2002
1
Colorectal Neoplasms (Colorectal Cancer)
06/2001
1
Lymphoma (Lymphomas)
06/2001
1
Thrombocytosis (Thrombocythemia)
05/2000
1
Myeloid Leukemia (Leukemia, Myelocytic)
05/2000
Drug/Important Bio-Agent (IBA)
3
Anaplastic Lymphoma Kinase
IBA
01/2022 - 02/2002
2
alectinib
IBA
01/2022 - 01/2018
2
Crizotinib
IBA
01/2022 - 01/2018
2
ErbB Receptors (EGF Receptor)
IBA
11/2018 - 08/2016
2
Docetaxel (Taxotere)
FDA Link
01/2018 - 03/2012
2
DNA (Deoxyribonucleic Acid)
IBA
05/2006 - 05/2001
2
Proteins (Proteins, Gene)
FDA Link
05/2005 - 05/2000
1
pralsetinib
IBA
11/2022
1
Creatine Kinase (Creatine Phosphokinase)
IBA
11/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Ipilimumab
IBA
01/2022
1
Thymidylate Synthase
IBA
01/2022
1
Nivolumab
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
11/2021
1
Endonucleases
IBA
11/2021
1
GTP Phosphohydrolases (GTPases)
IBA
11/2021
1
Phenobarbital (Luminal)
FDA Link
06/2019
1
Circulating Tumor DNA
IBA
11/2018
1
Tyrosine Kinase Inhibitors
IBA
11/2018
1
Pemetrexed (MTA)
FDA Link
01/2018
1
Gefitinib (Iressa)
FDA Link
08/2016
1
Cetuximab (Erbitux)
FDA Link
03/2012
1
Carboplatin (JM8)
FDA Link
Generic
03/2012
1
Immunoglobulins (Immunoglobulin)
IBA
05/2005
1
N 30
IBA
11/2004
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
11/2004
1
Interleukin-3 (Interleukin 3)
IBA
09/2004
1
Phosphotransferases (Kinase)
IBA
04/2003
1
Imatinib Mesylate (Gleevec)
FDA Link
04/2003
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
10/2001
1
Immunoconjugates (Immunoconjugate)
IBA
06/2001
Therapy/Procedure
11
Therapeutics
11/2022 - 05/2000
8
Drug Therapy (Chemotherapy)
04/2022 - 11/2004
3
Adjuvant Chemotherapy
04/2022 - 04/2013
1
Cranial Irradiation
01/2022
1
Radiotherapy
01/2022
1
Stem Cell Transplantation
04/2003